# FDA recall D-0906-2023

> **L. Perrigo Company** · Class II · drug recall initiated 2023-02-09.

## Product

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544.

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Nationwide within the USA

## Key facts

- **Recall number:** D-0906-2023
- **Recalling firm:** L. Perrigo Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-02-09
- **Report date:** 2023-07-19
- **Termination date:** 2023-09-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Allegan, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0906-2023

## Citation

> AI Analytics. FDA recall D-0906-2023. Retrieved 2026-07-16 from https://api.ai-analytics.org/recall/D-0906-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*